Federal officials are delaying changes to the policy that governs medical research on human subjects, just days before the changes were set to go into effect.

The changes to what’s known as the Common Rule — a federal policy that lays out the requirements for running research that involves human subjects — were supposed to be implemented starting on Jan. 19. But this week, the Department of Health and Human Services and 15 other agencies announced that the new policy would be delayed by six months to give the scientific community more time to prepare and to give the agencies more time to seek input from research institutions.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy